Hongocura ointment
- Manufacturer
- MENPER DISTRIBUTORS, INC. | RNV, LLC
- Effective date
- 2025-07-22
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 01:08:22
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Purpose
Undecylenic Acid 5%...................Antifungal
Zinc Undecylenate 20%...............Antifungal
OTC - PURPOSE SECTION
Purpose Antifungal
INDICATIONS & USAGE SECTION
Uses:
Proven effective in the treatment of athlete's foot (tinea pedis),jock itch (tinea cruris) and ringworm (tinea corporis).
For the effective relief of itching, burning, crackling and scaly skin between toes.
Clears up athlete's foot infection and with daily use, helps keep it from coming back.
WARNINGS SECTION
Warning:for external use only- Avoid contact with the eyes
Do not use:
On children under 2 years of age, unless directed by a doctor. For diaper rash. This product is not effective on the scalp or nails.
Stop use and ask a doctor if:For athlete's foot and ringworm, if irritation occurs or if there is no improvement within 4 weeks. For jock itch, if irritation occurs or if there is no improvment within 2 weeks
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep away of reach of children. In case of accidental ingestion, get medical help or contact a Posion Control Center, right away.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
DOSAGE & ADMINISTRATION SECTION
Directions:
Clean the affected area and dry throughly. Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor. Supervise children in use of this product. For athlete's foot: Pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily. For athlete's foot and ringworm, use daily for 4 weeks. For jock itch, use daily for 2 weeks, if condition persists longer, consult a doctor. This product is not effective for the scalp or nails.
INACTIVE INGREDIENT SECTION
Inactive ingredients: Methylparaben, propylparaben and white petrolatum
OTC - QUESTIONS SECTION
Questions?
www.menperdistributors.com or 1-800-560-5223, M-F 9 am- 4 pm EST
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53145-017-28 | 2023-07-28 | C162847 | 48780-1 | 0191ceaa-60fd-198a-e063-dbdaa90aec3e | Hongocura ointment |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53145-017-28 | Hongocura | 28 g in 1 TUBE | OINTMENT | 28 | 3 | |
| 53145-017-28 | Hongocura | 1 in 1 CARTON | OINTMENT | 1 | 3 |
Products#
Every source-derived product name is available through these pages.
- Hongocura
- undecylenic acid, zinc undecylenate
- METHYLPARABEN
- PROPYLPARABEN
- WHITE PETROLATUM
- UNDECYLENIC ACID
- ZINC UNDECYLENATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 53145-017 | 53145-017-28 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WHITE PETROLATUM | B6E5W8RQJ4 | IACT |
| UNDECYLENIC ACID | K3D86KJ24N | ACTIB |
| ZINC UNDECYLENATE | 388VZ25DUR | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hongocura | UNDECYLENIC ACID, ZINC UNDECYLENATE | MENPER DISTRIBUTORS, INC. | c69b735e-0ffe-4328-bd9f-3c1ac6798c08 | 2025-07-22 | Warnings | 53145-017-28 53145-017 53145001728 3a8931c9-1449-06ea-e063-6294a90a1df4 c69b735e-0ffe-4328-bd9f-3c1ac6798c08 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
